« Back
Home /
Bromocriptine (mesylate)

Bromocriptine (mesylate)

Item no.	HY-12705A-10mg
Manufacturer	MedChem Express
CASRN	22260-51-1
Amount	10 mg
Quantity options	100 mg 10 mM/1 mL 10 mg 200 mg 50 mg 5 mg
Category	Neuroscience Metabolism Cholesterol & Lipid Metabolism Targets for Rodent Neurosciences Enzymes Other Fatty Acid Enzymes Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	99.98
Citations	[1]Gardner B, et al. Agonist action at D2(long) dopamine receptors: ligand binding and functional assays. Br J Pharmacol. 1998 Jul;124(5):978-84.\|[2]Renodon A, et al. Bromocriptine is a strong inhibitor of brain nitric oxide synthase: possible consequences for the origin of its therapeutic effects.FEBS Lett. 1997 Apr 7;406(1-2):33-6.\|[3]Wynalda MA, et al. Assessment of potential interactions between dopamine receptor agonists and various human cytochrome P450 enzymes using a simple in vitro inhibition screen. Drug Metab Dispos. 1997 Oct;25(10):1211-4.\|[4]Rana DG, et al. Dopamine mediated antidepressant effect of Mucuna pruriens seeds in various experimental models of depression. Ayu. 2014 Jan;35(1):90-7.\|[5]Dieb W, et al. Nigrostriatal dopaminergic depletion increases static orofacial allodynia. J Headache Pain. 2016;17:11. Aquaculture. 2025 Apr 15.\|BMC Endocr Disord. 2021 Nov 23;21(1):235.\|Br J Pharmacol. 2021 Apr 26.\|Eur J Integr Med. 2021, 101322.\|Eur J Pharmacol. 2022: 175443.\|Int J Mol Sci. 2024 Nov 21;25(23):12483.\|J Biomol Struct Dyn. 2021 Sep 22;1-12.\|J Endocrinol Invest. 2024 Jun 26.\|J Ethnopharmacol. 2021 Mar 9;113994.\|Nat Commun. 2020 Feb 18;11(1):941. \|Sci Adv. 2021 Nov 26;7(48):eabj4624.\|Mol Pharm. 2022 Oct 21.\|Pharmacogn Mag. 2023 Oct 12.\|Toxicol Appl Pharmacol. 2024 Mar 2:116876.
Smiles	[H][C@@]12CC3=C(Br)NC4=CC=CC(C1=C[C@@H](C(N[C@@]5(C(C)C)C(N6[C@@H](CC(C)C)C(N7CCC[C@]7([C@]6(O)O5)[H])=O)=O)=O)CN2C)=C43.OS(=O)(C)=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	CB-154
Shipping Condition	Room temperature
Available
Manufacturer - Type	Reference compound
Manufacturer - Applications	Cancer-programmed cell death
Manufacturer - Targets	Autophagy; Dopamine Receptor
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, sealed storage, away from moisture and light)
Molecular Weight	750.70
Product Description	Bromocriptine mesylate is a potent dopamine D2/D3 receptor agonist, which binds D2 dopamine receptor with pKi of 8.05±0.2.
Manufacturer - Research Area	Neurological Disease; Cancer
Solubility	DMSO: 175 mg/mL (ultrasonic)\|H2O: 1.1 mg/mL (ultrasonic; adjust pH to 3 with HCl)
Manufacturer - Pathway	Autophagy; GPCR/G Protein; Neuronal Signaling
Isoform	D2 Receptor
Clinical information	Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-12705A-10mg-safety-datasheet.pdf